Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
The landscape of genomic analysis is shifting from basic detection to deep, integrated insights. Our technical roadmap focuses on the convergence of Digital PCR (dPCR), Next-Generation Sequencing (NGS), and Artificial Intelligence.
Transitioning beyond traditional qPCR to absolute quantification, enabling the detection of rare genetic mutations at concentrations below 0.1%.
Integrating machine learning algorithms directly into the hardware to reduce bioinformatic bottlenecks, providing real-time SNP and Indel analysis.
Developing portable, cartridge-based systems that bring the power of a central lab to the point-of-care, ensuring rapid response in infectious disease monitoring.
Future vistas include the integration of Multi-omics data, where genetic variation analysis systems will cross-reference genomic data with proteomic and metabolomic profiles to provide a holistic view of human health.
Our systems facilitate non-invasive cancer monitoring through the detection of Circulating Tumor DNA (ctDNA), allowing for early intervention and personalized therapy adjustment.
Custom OEM solutions for high-throughput screening of genetic variations that affect drug metabolism (CYP450 variants), reducing adverse drug reactions globally.
Scalable platforms for national-level pathogen genomic surveillance, providing the backbone for pandemic preparedness and rapid variant tracking.
BioX Medical leverages the "Shenzhen Advantage"—the world's most concentrated ecosystem for medical electronics and biotechnology. Our Factory 4.0 initiatives ensure that we don't just manufacture; we optimize.
Navigating the global regulatory landscape is the biggest hurdle in molecular diagnostics. BioX Medical provides a comprehensive compliance roadmap for our global partners:
Full support for CE-IVDR (EU), FDA 510(k) (USA), and NMPA (China) registrations, providing all necessary technical documentation and stability data.
Software UI/UX localization in 20+ languages and regional cloud server integration to comply with local data privacy laws (GDPR, HIPAA).
On-site and remote VR-assisted training for local engineering teams, ensuring the "BioX Quality" is maintained across all borders.
Supported by a multidisciplinary team of engineers, laboratory specialists, and quality management professionals, the company continuously invests in innovation and product development. Comprehensive quality control procedures are implemented throughout design, manufacturing, testing, and inspection processes to ensure consistent performance and compliance with international industry standards.
Shenzhen BioX Medical Co., Ltd. serves customers across Europe, North America, Asia-Pacific, the Middle East, Latin America, and Africa. The company also provides flexible OEM and ODM services for distributors, diagnostic companies, and healthcare organizations seeking customized molecular testing solutions.
For global enterprises, the cost of ownership is as critical as the technology itself. Our procurement framework is designed for long-term scalability:
Aggressive pricing structures for large-scale laboratory groups and national tenders, ensuring competitive ROI for diagnostic providers.
Total brand integration, including custom chassis design, proprietary software branding, and unique reagent optimization.
Open API architecture allowing seamless integration with existing Laboratory Information Management Systems for automated data reporting.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.